Assessing the safety of EO2002 after cataract surgery
Official title: Phase 1, Randomized, Masked, Sham-Controlled Study to Assess the Safety and Tolerability of EO2002 in Subjects Undergoing Cataract Surgery
Run by Asociación para Evitar la Ceguera en México · NCT05587205 · Data updated 2026-11-12
This study is testing if a new treatment called EO2002 is safe for people who have just had cataract surgery.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 32 (estimated) |
| Sponsor | Asociación para Evitar la Ceguera en México Academic / other |
| Locations | 1 site (Mexico City, Mexico City) |
| Status | Recruiting |
| Started | August 30, 2022 |
| Main results expected | October 6, 2026 |
| Study ends | October 6, 2026 |
| Registry record updated | December 8, 2025 |
| Trial ID | NCT05587205 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older with a history of uncomplicated cataracts requiring surgery and decreased endothelial cell counts.
✕Probably not a fit
Patients with other corneal diseases, significant macular disease, or recent ocular surgeries may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical study evaluates the safety and tolerability of EO2002, administered through an intracameral injection, in patients who have undergone cataract surgery. The trial focuses on individuals with a history of uncomplicated cataracts and decreased endothelial cell counts. Participants will receive either the EO2002 treatment or a sham injection to compare outcomes. The study aims to gather data on the safety profile of EO2002 in this specific patient population.
Why it matters
Potential benefit: If successful, this treatment could improve recovery and outcomes for patients undergoing cataract surgery.
How similar studies have gone: While this approach is novel in the context of EO2002, similar studies assessing safety in ocular treatments have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria: 1. Age ≥ 18 years. 2. Subject has uncomplicated history of cataract that has progressed to a level requiring standard cataract extraction with intraocular lens implant surgery. 3. Decreased endothelial cell count Exclusion Criteria: All ocular criteria apply to study eye unless otherwise noted. 1. Other corneal disease 2. Macular disease that in the investigator and/or sponsor's opinion would limit the ability of the subject to demonstrate improvement in BCVA. 3. Descemet membrane detachment. 4. History of uveitis or other ocular inflammatory disease. 5. History of incisional glaucoma surgery 6. Prior incisional eye surgery within 3 months prior to study treatment or penetrating or endothelial keratoplasty. 7. History of ocular neoplasm. 8. ETDRS BCVA in the fellow eye is worse than 35 letters (Snellen equivalent of 20/200). 9. Female who is pregnant, nursing, or planning to become pregnant, or who is of childbearing potential and not using a reliable means of contraception during the study. 10. Subject is currently participating in or has participated within the last 3 months in any other clinical trial of an investigational drug by ocular or systemic administration. 11. Any concomitant medical or psychological condition that could interfere with study participation or is otherwise not suitable for entry into the study in the opinion of the investigator.
Where it's running
-
Asociacion para Evitar la Ceguera en Mexico
Mexico City, Mexico City, Mexico Recruiting
Study contacts
- Principal investigator: Valeria Sanchez Huerta, MD — Asociacion para Evitar la Ceguera
- Study coordinator: Yara Luna
- Email: reclutamiento.proyectos@apec.com.mx
- Phone: 55 39 53 12 25
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Rotational Stability of the Acunex Vario Toric
This study tests whether the Acunex Vario toric extended-depth-of-focus intraocular lens stays stable in rotation and effectively reduces astigmatism for people undergoing cataract surgery.
-
Anterior segment anatomy assessment with swept-source OCT in eye surgery patients
This study tests whether swept-source OCT can detail front-eye anatomy in patients undergoing anterior segment eye surgery.
-
MiLOOP-assisted cataract surgery for dense cataracts
In people with dense cataracts, this study tests whether using the miLOOP device during cataract surgery can protect corneal cells and reduce ultrasound energy, compared with standard surgery.
-
Visual adaptation and quality of life after different IOL implantation options
This study follows adults who have cataracts and receive bilateral multifocal or mixed IOLs to see how their vision and daily life improve over 6 months.
-
EO2002 therapy for corneal edema due to endothelial dysfunction
This trial tests whether a single intracameral injection of EO2002 cells can improve vision and reduce corneal thickness in adults with corneal edema from endothelial dysfunction.
-
Corneal Biomechanics and Surgical Astigmatism after Cataract Surgery in Pseudoexfoliation
This study tests how the cornea's biomechanical properties before cataract surgery relate to the amount of blinking surgically induced astigmatism, comparing people with pseudoexfoliation to those without.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.